ArticleCancer & metabolism2026

PER2 knockdown drives immunotherapy resistance in gastric cancer via metabolic reprogramming of myeloid-derived suppressor cells.

Shenggang Zhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.